Everolimus in patients with metastatic renal cell carcinoma refractory to VEGF-targeted therapy: REACT subgroup analysis of prior therapy.
James M. G. Larkin
Consultant or Advisory Role - Novartis
Research Funding - Novartis
Christian U. Blank
Research Funding - Novartis
Petri Bono
Honoraria - Novartis
Research Funding - Novartis
Svetozar Gogov
Employment or Leadership Position - Novartis
Ashok Panneerselvam
Employment or Leadership Position - Novartis
Carlos A. Garay
Employment or Leadership Position - Novartis
Viktor Grünwald
Consultant or Advisory Role - Novartis
Honoraria - GlaxoSmithKline; Novartis; Pfizer; Roche
Research Funding - Novartis